Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:1970766rdf:typepubmed:Citationlld:pubmed
pubmed-article:1970766lifeskim:mentionsumls-concept:C1280551lld:lifeskim
pubmed-article:1970766lifeskim:mentionsumls-concept:C0031327lld:lifeskim
pubmed-article:1970766lifeskim:mentionsumls-concept:C0025519lld:lifeskim
pubmed-article:1970766lifeskim:mentionsumls-concept:C0033497lld:lifeskim
pubmed-article:1970766lifeskim:mentionsumls-concept:C0205177lld:lifeskim
pubmed-article:1970766lifeskim:mentionsumls-concept:C0870883lld:lifeskim
pubmed-article:1970766pubmed:issue1lld:pubmed
pubmed-article:1970766pubmed:dateCreated1990-6-14lld:pubmed
pubmed-article:1970766pubmed:abstractTextThe disposition of 4'-hydroxypropranolol (HOP) was determined after iv administration to dogs (2 mg/kg; N = 5) and the pharmacokinetic parameters were calculated from plasma measurements. The clearance of HOP, 66 +/- 6 ml/min/kg (mean +/- SE), was considerably higher than that of propranolol previously determined, suggesting extrahepatic as well as hepatic clearance of HOP. The plasma half-life of HOP, 77 +/- 6 min, was shorter than that of propranolol. Although HOP is considerably less lipophilic than propranolol, its volume of distribution, 6.4 +/- 0.8 liter/kg, surprisingly, was larger. Like propranolol, HOP appeared to be cleared entirely by metabolism. Whereas propranolol is metabolized mainly by oxidation, HOP was metabolized to sulfate (HOPS) and glucuronic acid (HOPG) conjugates. The plasma half-lives of these conjugates were 2 to 3 times longer than for HOP, reflecting a slow, continuous formation from HOP. This was established for HOPS by iv administration of synthetic HOPS. Morover, after HOP administration both formation and renal clearance of HOPS were stereoselective in favor of the R-enantiomer. In summary, the main conclusion of this study is that the large volume of distribution as well as high clearance through sulfation and glucuronidation may explain the low plasma HOP levels observed during propranolol therapy.lld:pubmed
pubmed-article:1970766pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1970766pubmed:languageenglld:pubmed
pubmed-article:1970766pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1970766pubmed:citationSubsetIMlld:pubmed
pubmed-article:1970766pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1970766pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1970766pubmed:statusMEDLINElld:pubmed
pubmed-article:1970766pubmed:issn0090-9556lld:pubmed
pubmed-article:1970766pubmed:authorpubmed-author:WalleTTlld:pubmed
pubmed-article:1970766pubmed:authorpubmed-author:WalleU KUKlld:pubmed
pubmed-article:1970766pubmed:authorpubmed-author:OatisJ EJEJrlld:pubmed
pubmed-article:1970766pubmed:authorpubmed-author:ChristD DDDlld:pubmed
pubmed-article:1970766pubmed:issnTypePrintlld:pubmed
pubmed-article:1970766pubmed:volume18lld:pubmed
pubmed-article:1970766pubmed:ownerNLMlld:pubmed
pubmed-article:1970766pubmed:authorsCompleteYlld:pubmed
pubmed-article:1970766pubmed:pagination1-4lld:pubmed
pubmed-article:1970766pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:1970766pubmed:meshHeadingpubmed-meshheading:1970766-...lld:pubmed
pubmed-article:1970766pubmed:meshHeadingpubmed-meshheading:1970766-...lld:pubmed
pubmed-article:1970766pubmed:meshHeadingpubmed-meshheading:1970766-...lld:pubmed
pubmed-article:1970766pubmed:meshHeadingpubmed-meshheading:1970766-...lld:pubmed
pubmed-article:1970766pubmed:meshHeadingpubmed-meshheading:1970766-...lld:pubmed
pubmed-article:1970766pubmed:meshHeadingpubmed-meshheading:1970766-...lld:pubmed
pubmed-article:1970766pubmed:meshHeadingpubmed-meshheading:1970766-...lld:pubmed
pubmed-article:1970766pubmed:meshHeadingpubmed-meshheading:1970766-...lld:pubmed
pubmed-article:1970766pubmed:articleTitlePharmacokinetics and metabolism of the pharmacologically active 4'-hydroxylated metabolite of propranolol in the dog.lld:pubmed
pubmed-article:1970766pubmed:affiliationDepartment of Cell and Molecular Pharmacology and Experimental Therapeutics, Medical University of South Carolina, Charleston 29425.lld:pubmed
pubmed-article:1970766pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:1970766pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1970766lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1970766lld:pubmed